SUMMIT (OXFORD) LIMITED

136A EASTERN AVENUE, MILTON PARK, ABINGDON  OX14 4SB
  • Active
  • Private Limited Company
  • Company No. 04636431
  • Last Updated: 01 Mar 2024

Company Profile

SUMMIT (OXFORD) LIMITED was incorporated on Tuesday, January 14, 2003 as a Private Limited Company with registered address in ABINGDON. SUMMIT (OXFORD) LIMITED has the status: Active and it's listed in the following category: Research and experimental development on biotechnology. This Private Limited Company has been operating for 22 years 1 month and 9 days.

Name SUMMIT (OXFORD) LIMITED
Company number 04636431
Company type Private Limited Company
Incorporation date 14 Jan 2003
Status Active
Industry (SIC 2007)

Address

Registered Address 136A EASTERN AVENUE
MILTON PARK
ABINGDON
OX14 4SB
Country Of Origin UNITED KINGDOM

Map based on PostCode

Ownership Information

Individuals and organizations with significant control over the business either by owning at least 25% shares or by virtue of significant influence over the business.

Name Nature of Control
Summit Therapeutics Limited Eastern Avenue, Milton, OX14 4SB Dates: Wednesday, April 6, 2016 - present
ownership of shares 75 to 100 percent
voting rights 75 to 100 percent
right to appoint and remove directors

Accounts and Confirmation

Type of accounts FULL
End of financial Year 31 December
Next annual accounts due 30 September 2024, (-146 days left)
Latest accounts 31 December 2022
Next confirmation statement due 11 February 2017
Last confirmation statement dated 14 January 2016

Mortgages

No mortgages have been registered against SUMMIT (OXFORD) LIMITED.

Previous Names

Name Change Date
SUMMIT (OXFORD) LIMITED 14 Jan 2003
VASTOX LIMITED 30 Sep 2004
VASTOX CHEMICAL GENOMICS LIMITED 06 Aug 2007